cycloheximide has been researched along with anthralin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klem, EB | 1 |
| Aizu, E; Kato, R; Yamamoto, S | 1 |
| Bisschop, A; Uijtewaal, B; van Wijk, R; Vankan, PM | 1 |
3 other study(ies) available for cycloheximide and anthralin
| Article | Year |
|---|---|
Effects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture.
Topics: Animals; Anthralin; Antimetabolites; Azauridine; Cell Division; Cells, Cultured; Cycloheximide; Cytarabine; Dactinomycin; Daunorubicin; Guinea Pigs; Hydroxyurea; Methotrexate; Mycophenolic Acid; Psoriasis; Puromycin; Skin | 1978 |
Anthralin, a non-TPA type tumor promoter, synergistically enhances phorbol ester-caused prostaglandin E2 release from primary cultured mouse epidermal cells.
Topics: Animals; Anthralin; Arachidonic Acid; Carcinogens; Cells, Cultured; Cycloheximide; Dactinomycin; Dinoprostone; Drug Synergism; Epidermis; Mice; Prostaglandin-Endoperoxide Synthases; Radioimmunoassay; Tetradecanoylphorbol Acetate | 1992 |
Effect of 1,8-dihydroxy-9-anthrone (anthralin) on rat hepatic ornithine decarboxylase activity in vivo.
Topics: Animals; Anthracenes; Anthralin; Cycloheximide; Dactinomycin; Enzyme Activation; Injections, Intraperitoneal; Liver; Male; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Rats; Rats, Inbred Strains; Time Factors | 1984 |